| Name | hemoglobin (protein family or complex) |
|---|---|
| Synonyms | Hemoglobin; Hemoglobins |
| Name | DMPA |
|---|---|
| CAS |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 9883381 | : Effects of contraceptives on hemoglobin and ferritin. Contraception. 1998 Nov;58(5):262-73. The effects of combined oral contraceptives (OC), depot medroxyprogesterone acetate injections (DMPA), levonorgestrel subdermal implant (Norplant), -containing intrauterine devices IUD), and Chinese stainless steel ring IUD on hemoglobin and ferritin were studied in 18-40-year-old, nonpregnant, and nonlactating women in seven countries (Bangladesh, Chile, China, the Dominican Republic, Pakistan, Thailand, and Tunisia). |
14(0,0,1,9) | Details |
| 16100628 | Demers C, Derzko C, David M, Douglas J: Gynaecological and obstetric management of women with inherited bleeding disorders. J Obstet Gynaecol Can. 2005 Jul;27(7):707-32. Because underlying bleeding disorders are frequent in women with menorrhagia, physicians should consider performing a hemoglobin/hematocrit, platelet count, ferritin, PT (INR) and APTT in women with menorrhagia. An inherited bleeding disorder is not a contraindication to hormonal therapy (oral contraceptives [II-1B], depot medroxyprogesterone acetate (DMPA) [II-3B], danazol [II-2B], GnRH analogs [II-3B]) or local treatments (levonorgestrel-releasing IUS [II-1B]) and non-hormonal therapy (antifibrinolytic drug tranexamic acid [II-1B]) as well as desmopressin (II-1B). |
1(0,0,0,1) | Details |
| 18669758 | Yauger BJ, Gorden P, Park J, Cochran E, Stratton P: Effect of depot medroxyprogesterone acetate on tolerance in generalized lipodystrophy. Obstet Gynecol. 2008 Aug;112(2 Pt 2):445-7. Depot medroxyprogesterone acetate (DMPA), a commonly used contraceptive, may worsen tolerance in diabetics and those with lipodystrophy. CASE: A young woman with generalized lipodystrophy, who previously required greater than 1,000 units of insulin daily, had a normal hemoglobin A1c on leptin and only. |
1(0,0,0,1) | Details |
| 17106950 | Demers C, Derzko C, David M, Douglas J: Gynaecological and obstetric management of women with inherited bleeding disorders. Int J Gynaecol Obstet. 2006 Oct;95(1):75-87. Because underlying bleeding disorders are frequent in women with menorrhagia, physicians should consider performing a hemoglobin/hematocrit, platelet count, ferritin, PT (INR) and APTT in women with menorrhagia. An inherited bleeding disorder is not a contraindication to hormonal therapy (oral contraceptives [II-1B], depot medroxyprogesterone acetate (DMPA) [II-3B], danazol [II-2B], GnRH analogs [II-3B]) or local treatments (levonorgestrel-releasing IUS [II-1B]) and non-hormonal therapy (antifibrinolytic drug tranexamic acid [II-1B]) as well as desmopressin (II-1B). |
1(0,0,0,1) | Details |
| 12316139 | Abdel-sayed WS, Toppozada HK, Said SA, El-sayed OK: Some metabolic and hormonal changes in women using long acting injectable contraceptives. Alex J Pharm Sci. 1989 Mar;3(1):29-32. The 2 main injectables utilized were depomedroxyprogesterone (DMPA), given every 90 +or- 5 days, and norethisterone (NET/EN) injected every 60 +or- 5 days. |
0(0,0,0,0) | Details |